Moderna's mRNA Flu Vaccine Nears FDA Approval Amid Review Uncertainty

SentiSense · Published Jun 17, 2026, 2:30 AM ET · Updated Jun 17, 2026, 5:51 PM ET

Moderna's mRNA-based flu vaccine, mFlusiva, is set for FDA review despite regulatory concerns. The vaccine met all efficacy criteria but faces scrutin...